1. Volume 14, Issue 4, Pages 317-326 (April 2013)
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial 
Dr Somnath Mukherjee, FRCP, Christopher N Hurt, MSc, John Bridgewater, MD, Stephen Falk, MD, Sebastian Cummins, MRCP, Harpreet Wasan, FRCR, Tom Crosby, FRCR, Catherine Jephcott, FRCR, Rajarshi Roy, FRCR, Ganesh Radhakrishna, FRCR, Alec McDonald, MD, Ruby Ray, PhD, George Joseph, MBBS, John Staffurth, MD, Prof Ross A Abrams, MD, Gareth Griffiths, MSc, Prof Tim Maughan, FRCR 
The Lancet Oncology 
Volume 14, Issue 4, Pages (April 2013)
DOI: /S (13)
Copyright © 2013 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet Oncology  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan–Meier estimates of progression-free survival, by treatment group
The Lancet Oncology  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

4. Figure 3
Kaplan–Meier estimates of overall survival, by treatment group
The Lancet Oncology  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

5. Figure 4 Quality of life scores
Scores are from the QLQ-C30 questionnaire. Error bars show 95% CIs.
The Lancet Oncology  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions